ArticleJournal of the Chinese Medical Association : JCMA2026

Risk factors of hepatotoxicity with ribociclib in hormone receptor-positive breast cancer.

Wei-Chi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.